InvestorsHub Logo
Followers 62
Posts 7597
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Tuesday, 06/11/2024 9:48:06 AM

Tuesday, June 11, 2024 9:48:06 AM

Post# of 428507
About an Amarin AG for Vascepa...Profitability could be achieved by...

-really high sales volumes of Vascepa sales by Amarin due to lower Vascepa prices and (Amarin) generic V prices in the U.S. and elsewhere...This would be made possible by...really low prices of API to Amarin from its suppliers...This would, in turn, be made possible by
-really increased EPA sales volumes in Europe, together with the ROW(which other generics could not match)

Its a challenge, but what other options are available to Amarin?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News